相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D
Ben L. Da et al.
ANTIVIRAL RESEARCH (2020)
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander J. Stockdale et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatitis Delta Prevalence, Natural History, and Treatment Options
Julian Hercun et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Noninvasive markers for staging fibrosis in chronic delta hepatitis
V. Takyar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Long-term therapy of chronic delta hepatitis with peginterferon alfa
T. Heller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Understanding Early Serum Hepatitis D Virus and Hepatitis B Surface Antigen Kinetics During Pegylated Interferon-alpha Therapy Via Mathematical Modeling
Jeremie Guedj et al.
HEPATOLOGY (2014)
Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta
Denis Ouzan et al.
JOURNAL OF HEPATOLOGY (2013)
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Lisa I. Backus et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Excess Mortality in Patients with Advanced Chronic Hepatitis C Treated with Long-Term Peginterferon
Adrian M. Di Bisceglie et al.
HEPATOLOGY (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression
Sarah Gheuens et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis
C. Yurdaydin et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
Grazia Anna Niro et al.
HEPATOLOGY (2006)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Long-term benefit of interferon a therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
P Farci et al.
GASTROENTEROLOGY (2004)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
分享论文
